-
12641por Kiser, Jennifer J., Lu, Darlene, Rosenkranz, Susan L., Morse, Gene D., DiFrancesco, Robin, Sherman, Kenneth E., Butt, Adeel A.“…OBJECTIVE: The objective of this study was to determine the magnitude of drug interactions between the hepatitis C virus (HCV) protease inhibitor boceprevir (BOC) and antiretroviral (ARV) agents in persons with HIV/HCV co-infection. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12642por Huang, Peng, Fan, Haozhi, Tian, Ting, Liao, Peiwen, Li, Jun, Yu, Rongbin, Xia, Xueshan, Feng, Yue, Wang, Jie, Liu, Yuan, Zhang, Yun, Yue, Ming“…BACKGROUND: Recently, human leukocyte antigen (HLA) class-II gene polymorphisms have been reported to be related to Hepatitis C virus (HCV) infection and chronicity. The objective of this study was to explore the relationship of HLA-DP rs9277535 and HLA-DQ rs7453920 with the outcomes of HCV infection. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12643por Zekri, Abdel Rahman N, Salama, Hosny, Medhat, Eman, Hamdy, Sherif, Hassan, Zeinab K, Bakr, Yasser Mabrouk, Youssef, Amira Salah El - Din, Saleh, Doaa, Saeed, Ramy, Omran, Dalia“…METHODS: Serum folic acid and lymphocytic mtDNA deletions were assessed in 90 patients; 50 with HCC, 20 with liver cirrhosis (LC), and 20 with chronic hepatitis C (CHC) compared to 10 healthy control subjects. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12644por Page, Sandra J., Rivera, Maria M., Kleiner, David E., Zhao, Xiongce, Auh, Sungyoung, Remmers, Elaine F., Heller, Theo“…Approximately 71 million people are chronically infected with the hepatitis C virus (HCV), a potentially lethal pathogen. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12645por Smith, Joshua W., Kroker-Lobos, Maria F., Lazo, Mariana, Rivera-Andrade, Alvaro, Egner, Patricia A., Wedemeyer, Heiner, Torres, Olga, Freedman, Neal D., McGlynn, Katherine A., Guallar, Eliseo, Groopman, John D., Ramirez-Zea, Manuel“…Biomarkers of hepatitis B virus and hepatitis C virus infection were assessed by immunoassay and analyzed by Fisher’s exact test. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12646por Memon, Saba Samad, Tandon, Nikhil, Mahajan, Sandeep, Bansal, V. K., Krishna, Asuri, Subbiah, Arunkumar“…Increased age was a significant risk factor for NODAT (P = 0.000), whereas gender, acute rejection episodes, cadaveric transplant, hepatitis C virus status, human leukocyte antigen mismatch, and high calcineurin levels were not significantly associated with the future development of NODAT. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12647por Warzyszyńska, Karola, Jonas, Maurycy, Wasiak, Dariusz, Kosieradzki, Maciej, Małkowski, Piotr“…AIM OF THE STUDY: New interferon-free direct-acting antiviral (DAA) therapy has led to major progress in hepatitis C virus (HCV) treatment. Current outcomes are promising, especially in compensated cirrhosis. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12648por Li, Tsai-Chung, Li, Chia-Ing, Liu, Chiu-Shong, Lin, Pao-Hsuan, Lin, Wen-Yuan, Lin, Chih-Hsueh, Yang, Sing-Yu, Chiang, Jen-Huai, Lin, Cheng-Chieh“…Significant hazard ratios of HCC for patients with a level of ALT ≥ 40 U/L and alcoholic liver damage, nonalcoholic fatty liver disease, liver cirrhosis, hepatitis B virus and hepatitis C virus infection, or any one of these chronic liver diseases compared with patients with ALT level < 40 U/L and no counterpart comorbidity were observed. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12649“…We recently reported that simeprevir, an anti-hepatitis C viral (HCV) agent, radiosensitized diverse human cancer cells by inhibiting PI4K IIIα in vitro. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12650por Lee, Hsing-Feng, Liu, Pei-Yi, Wang, Yen-Po, Tsai, Chia-Fen, Chang, Full-Young, Lu, Ching-Liang“…Age- and sex-matched healthy carriers of chronic hepatitis B or hepatitis C without chronic abdominal symptoms were identified as disease-controls. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12651por Kim, Yong Chan, Ahn, Jin Young, Kim, June Myung, Kim, Youn Jeong, Park, Dae Won, Yoon, Young Kyung, Song, Joon Young, Kim, Shin Woo, Lee, Jin Soo, Choi, Bo Youl, Choi, Yun Su, Choi, Ju-yeon, Han, Myung Guk, Kang, Chun, Choi, Jun Yong“…BACKGROUND: Despite declines in mortality and morbidity rates of patients with human immunodeficiency virus (HIV) infection as the result of highly active antiretroviral therapy, liver diseases due to chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are a leading cause of death among HIV-infected patients. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12652por Madabhavi, Irappa, Modi, Gaurang, Panchal, Harsha, Patel, Apurva, Revannasiddaiah, Swaroop, Anand, Asha, Parikh, Sonia, Joshi, Kshitij, Sarkar, Malay“…First patient was a 63-year-old female with hepatitis C virus seropositivity presented with liver mass simulating hepatocellular carcinoma. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12653por Zule, William A., Pande, Poonam G., Otiashvili, David, Bobashev, Georgiy V., Friedman, Samuel R., Gyarmathy, V. Anna, Des Jarlais, Don C.“…BACKGROUND: When shared by people who inject drugs, needles and syringes with different dead space may affect the probability of HIV and hepatitis C virus (HCV) transmission differently. METHODS: We measured dead space in 56 needle and syringe combinations obtained from needle and syringe programs across 17 countries in Europe and Asia. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12654por Mesci, Pinar, Macia, Angela, Moore, Spencer M., Shiryaev, Sergey A., Pinto, Antonella, Huang, Chun-Teng, Tejwani, Leon, Fernandes, Isabella R., Suarez, Nicole A., Kolar, Matthew J., Montefusco, Sandro, Rosenberg, Scott C., Herai, Roberto H., Cugola, Fernanda R., Russo, Fabiele B., Sheets, Nicholas, Saghatelian, Alan, Shresta, Sujan, Momper, Jeremiah D., Siqueira-Neto, Jair L., Corbett, Kevin D., Beltrão-Braga, Patricia C. B., Terskikh, Alexey V., Muotri, Alysson R.“…Sofosbuvir (SOF), an FDA-approved nucleotide analog inhibitor of the Hepatitis C (HCV) RNA-dependent RNA polymerase (RdRp) was recently shown to be protective against ZIKV both in vitro and in vivo. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12655por Ochiai, Yushi, Sano, Emiko, Okamoto, Yutaka, Yoshimura, Sodai, Makita, Kotaro, Yamamuro, Shun, Ohta, Takashi, Ogino, Akiyoshi, Tadakuma, Hisashi, Ueda, Takuya, Nakayama, Tomohiro, Hara, Hiroyuki, Yoshino, Atsuo, Katayama, Yoichi“…Ribavirin, a nucleic acid analog, has been employed as an antiviral agent against RNA and DNA viruses and has become the standard agent used for chronic hepatitis C in combination with interferon-α2a. Furthermore, the potential antitumor efficacy of ribavirin has attracted increasing interest. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12656“…The global prevalence of hepatitis C Virus (HCV) is approximately 3% and one-fifth of all HCV carriers live in the Middle East, where Egypt has the highest global incidence of HCV infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12657por Aïm-Eusébi, Amélie, Prothon, Emmanuel, Majerholc, Catherine, Barger, Diana, Yazdanpanah, Yazdan, Aubert, Jean-Pierre“…Background: Many people in Europe remain undiagnosed for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV). Objectives: To evaluate acceptability and effectiveness of a questionnaire designed to facilitate identification of risk factors for these viruses. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12658por Marcon, Patrícia dos Santos, Tovo, Cristiane Valle, Kliemann, Dimas Alexandre, Fisch, Patrícia, de Mattos, Angelo Alves“…AIM: To assess the incidence of hepatocellular carcinoma (HCC) in chronic liver disease due to hepatitis B virus (HBV) or hepatitis C virus (HCV) coinfected with human immunodeficiency virus (HIV). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12659“…The same population had low prevalence of malaria (7%) and hepatitis C (up to 5%). There have been recent case reports from European countries of cutaneous diphtheria, louse-born relapsing fever, and shigella in the asylum-seeking and refugee population. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12660por Takamatsu, Yuichi, Hori, Tomohide, Machimoto, Takafumi, Hata, Toshiyuki, Kadokawa, Yoshio, Ito, Tatsuo, Kato, Shigeru, Yasukawa, Daiki, Aisu, Yuki, Kimura, Yusuke, Kitano, Taku, Yoshimura, Tsunehiro“…CASE REPORT: A 58-year-old female with chronic hepatitis C developed a solitary hepatic cellular carcinoma with portal tumor thrombosis. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto